Srijon K. Banerjee
Postdoctoral Research Fellow
Also affiliated: Bose Institute (2013–2022); University of Pittsburgh (2022–2024)
Formerly Arkansas Affiliated with UAMS through 2024.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Srijon K. Banerjee's research focuses on understanding the molecular mechanisms of bacterial infections, particularly those caused by *Mycobacterium tuberculosis*. His work investigates how bacteria regulate their stress responses and interact with host immune cells. He has studied the role of specific bacterial proteins and genetic regulatory elements, such as polyphosphate kinase 1 and the MtrAB two-component system, in bacterial survival and pathogenesis. Additionally, his research explores how host immune signaling pathways, including microRNAs and cytokine regulation, influence macrophage responses and bacterial trafficking during infection. He also contributes to research on disease models, including the use of human precision-cut lung slices to study pneumonic plague and the role of bacterial proteases in infection.
Banerjee is involved in a large NIH-funded project focused on developing platforms for quantitative imaging informatics in precision medicine. This project, where he serves as a Co-PI, received $1,591,584 from the National Cancer Institute. His publication record includes work on bacterial cell growth and division, innate immune signaling, and host-pathogen interactions. His scholarship metrics include an h-index of 10, with 18 total publications and 487 total citations.
Metrics
- h-index: 10
- Publications: 18
- Citations: 487
Positions
-
Postdoctoral Research Fellow 2020–presentUniversity of Pittsburgh Microbiology and Molecular Genetics ORCID
-
Postdoctoral Research Fellow publications 2019–2024University of Arkansas for Medical Sciences ORCID
-
Postdoctoral Research Scholar 2017–2020University of Arkansas for Medical Sciences Microbiology and Immunology ORCID
Selected Publications
-
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2024)
-
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy (2023)
-
The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague (2020)
-
A Dual Role for the Plasminogen Activator Protease During the Preinflammatory Phase of Primary Pneumonic Plague (2020)
-
Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion (2019)
Federal Grants 1 $1,591,584 total
Collaboration Network
Top Collaborators
- Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion
- A Dual Role for the Plasminogen Activator Protease During the Preinflammatory Phase of Primary Pneumonic Plague
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- A Dual Role for the Plasminogen Activator Protease During the Preinflammatory Phase of Primary Pneumonic Plague
- The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion
- Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion
- The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague
- The Yersinia pestis GTPase BipA Promotes Pathogenesis of Primary Pneumonic Plague
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
- An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
Similar Researchers
Based on overlapping research topics